Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Nabriva Therapeutics's Days Inventory or its related term are showing as below:
NBRVF's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 180.895 * Ranked among companies with meaningful Days Inventory only.
Nabriva Therapeutics's Days Inventory
declined
from Jun. 2022 (319.19) to Jun. 2023 (90.78).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nabriva Therapeutics's Inventory Turnover for the
three
months ended in Jun. 2023 was 1.01.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nabriva Therapeutics's Inventory-to-Revenue for the
three
months ended in Jun. 2023 was 3.51.
Nabriva Therapeutics (OTCPK:NBRVF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Nabriva Therapeutics's Inventory Turnover for the
three
months ended in Jun. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nabriva Therapeutics's Inventory to Revenue for the
three
months ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Nabriva Therapeutics Days Inventory Related Terms
Nabriva Therapeutics Days Inventory Historical Data
* Premium members only.
The historical data trend for Nabriva Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NBRVF vs BXRX, INM, ADTX: Days Inventory Comparison
For the Biotechnology subindustry, Nabriva Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nabriva Therapeutics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nabriva Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Nabriva Therapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nabriva Therapeutics (NBRVF) has a Days Inventory of 90.78 as of Jun. 2023. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nabriva Therapeutics and its competitors.
Is Nabriva Therapeutics' Days Inventory too high?
Nabriva Therapeutics' current Days Inventory is 90.78. The Biotechnology industry median Days Inventory is 180.90. Nabriva Therapeutics' value of 90.78 is 49.8% below this industry median. Overall, Nabriva Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Nabriva Therapeutics' Days Inventory compare to BXRX and INM?
Nabriva Therapeutics' Days Inventory of 90.78 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 180.90. Nabriva Therapeutics' value of 90.78 is 49.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 180.90, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nabriva Therapeutics's current Days Inventory of 90.78 is 49.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nabriva Therapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 180.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nabriva Therapeutics's current Days Inventory is 90.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nabriva Therapeutics stock overvalued right now?
Nabriva Therapeutics (NBRVF) has a current Days Inventory of 90.78. The current Days Inventory is 90.78 and 49.8% below the Biotechnology industry median of 180.90. Nabriva Therapeutics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Nabriva Therapeutics (NBRVF), the current Days Inventory is 90.78 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. The company is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company has developed a product candidate, XENLETA, a semi-synthetic pleuromutilin antibiotic that is the first in its class for oral and IV administration in humans. The firm has commercial rights to two approved products, SIVEXTRO and XENLETA, as well as one development product candidate, CONTEPO.
12GF Score
Get the complete analysis for NBRVF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NBRVF has been successfully added to your 
